TCRX
Tscan Therapeutics Inc
0.34$
-2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -278.6% | -480.0% | -491.3% | -291.5% | -3,935.4% | -1,310.6% | |
| – | 113.4% | 32.8% | 38.0% | 25.5% | 145.9% | 27.8% | |
| – | 47.5% | 24.8% | 33.6% | 24.7% | 339.1% | 113.4% | |
| – | 47.6% | 24.8% | 33.6% | – | – | – | |
| – | 1,968.4% | -58.1% | -75.6% | 83.6% | 179.5% | -176.1% | |
| – | 390.6% | 98.0% | 31.2% | 14.9% | 135.8% | 42.7% | |
| – | -390.6% | -98.0% | -31.2% | -288.7% | -1,868.4% | 1,059.3% | |
| – | – | – | – | – | 0.0% | 0.0% | |
| – | – | 1,870.3% | 2.4% | – | – | 2.6% | |
| – | 2,705.4% | 289.5% | 214.5% | 0.0% | 543.8% | 0.0% | |
| – | 26.5% | 1,870.3% | 216.9% | 643.5% | 7,413.5% | -3.3% | |
| – | -642.7% | 1,292.3% | -305.7% | 63.3% | 1,609.7% | -254.6% | |
| – | -669.2% | -578.0% | -522.6% | -306.4% | -4,071.3% | -1,353.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.